Intron 10 was targeted with two sgRNAs using CRISPR/Cas9 technology, resulting in a 268 bp deletion (GRCm39:chr17:27178158-27178425). This deletion eliminates the alternative 3' splice acceptor site that is used for NMD-mediated transcriptional regulation. (J:334714)